col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


10 Ergebisse       Seite 1

 [1] 
Srinivas University: International Journal of Health Sciences and Pharmacy
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Aug―19 Impact of COVID-19 Lockdown: Stratified Livelihoods in Nepal a Sociological Analysis Shukra Raj Adhikari, Bhawani Shankar Adhikari, Ganga Acharya, A. K. Mishra
2 [GO] 2023―Okt―25 Classification of Pneumonia and Covid-19 using Convolutional Neural Network A. K. Mishra, Aanchal Ghimire, Mamata Joshi, Srijana Khatiwada, Naw Raj Joshi, P. B. Jha Jha, P. S. Aithal
3 [GO] 2022―Jun―17 Lockdown: The Most Effective Preventive Measurement of Corona Virus Pandemic Disease through Social Distancing Sandip Roy, Priyanka Bhattacharya, Rajesh Bose, Haraprasad Mondal, Indranil Sarkar
4 [GO] 2021―Nov―27 A Study on the Implications of COVID-19 Pandemic on Families with Autism Spectrum Disorder Menezes Ida Sylvia, K. T. Shwetha, Laveena D’Mello
5 [GO] 2021―Aug―02 Students’ Perceptions of the Impact of Online Education on Health during COVID-19: A Survey Study Krishna Prasad K., Geetha Poornima K., Rajeshwari M.
6 [GO] 2021―Mai―19 Integration of Adaptive Technologies with Healthcare for the Early Identification and Control of COVID-19 Pandemic Disease Geetha Poornima K., Rajeshwari M., Krishna Prasad K.
7 [GO] 2021―Mai―14 Zuber’s Coronavirus Disease (COVID- 19) Standards for Hospitals Zuber Mujeeb Shaikh
8 [GO] 2021―Mai―02 An AI-based Analysis of the effect of COVID-19 Stringency Index on Infection rates: A case of India Krishna Prasad K., P. S. Aithal, Geetha Poornima K.
9 [GO] 2021―Mrz―26 Human Resource Professional Priorities and Challenges in Times of COVID-19 Pandemic Shammy Shiri, Laveena D'Mello
10 [GO] 2021―Mrz―26 An Overview of Drugs Used in COVID-19: A Pharmacotherapeutic Approach Archith Aithal, Edwin Dias
 [1] 

10 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.005 sec